Page 34 - Read Online

Page 10 of 14 Woods et al. J Cancer Metastasis Treat 2022;8:22 https://dx.doi.org/10.20517/2394-4722.2022.28

4. Pisani P, Ramponi A, Pia F. The deep parotid lymph nodes: an anatomical and oncological study. J Laryngol Otol 1996;110:148-50.
DOI PubMed
5. Stonesifer CJ, Djavid AR, Grimes JM, et al. Immune checkpoint inhibition in non-melanoma skin cancer: a review of current
evidence. Front Oncol 2021;11:734354. DOI PubMed PMC
6. Franzen A, Buchali A, Lieder A. The rising incidence of parotid metastases: our experience from four decades of parotid gland
surgery. Acta Otorhinolaryngol Ital 2017;37:264-9. DOI PubMed PMC
7. Swanson MS, Sinha UK. Diagnosis and management of merkel cell carcinoma of the head and neck: current trends and controversies.
Cancers (Basel) 2014;6:1256-66. DOI PubMed PMC
8. McLean T, Brunner M, Ebrahimi A, et al. Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma:
Analysis of prognostic factors. Head Neck 2013;35:1144-8. DOI PubMed
9. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell
carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 2013;149:541-7. DOI PubMed
10. Khurana VG, Mentis DH, O’brien CJ, Hurst TL, Stevens GN, Packham NA. Parotid and neck metastases from cutaneous squamous
cell carcinoma of the head and neck. Am J Surg 1995;170:446-50. DOI PubMed
11. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma:
a prospective study. Lancet Oncol 2008;9:713-20. DOI PubMed
12. Karia PS, Morgan FC, Ruiz ES, Schmults CD. Clinical and incidental perineural invasion of cutaneous squamous cell carcinoma: a
systematic review and pooled analysis of outcomes data. JAMA Dermatol 2017;153:781-8. DOI PubMed PMC
13. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of
the skin, ear, and lip. J Am Acad Dermatol 1992;26:976-90. DOI PubMed
14. Newlands C, Currie R, Memon A, Whitaker S, Woolford T. Non-melanoma skin cancer: United Kingdom National Multidisciplinary
Guidelines. J Laryngol Otol 2016;130:S125-32. DOI PubMed PMC
15. Haug K, Breuninger H, Metzler G, et al. Prognostic impact of perineural invasion in cutaneous squamous cell carcinoma: results of a
prospective study of 1399 tumors. J Invest Dermatol 2020;140:1968-75. DOI PubMed
16. Thompson AK, Kelley BF, Prokop LJ, Murad MH, Baum CL. Risk factors for cutaneous squamous cell carcinoma recurrence,
metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol 2016;152:419-28. DOI PubMed
PMC
17. Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part
1. epidemiology, diagnostics and prevention. Eur J Cancer 2020;128:60-82. DOI PubMed
18. Harris BN, Bayoumi A, Rao S, Moore MG, Farwell DG, Bewley AF. Factors Associated with Recurrence and Regional Adenopathy
for Head and Neck Cutaneous Squamous Cell Carcinoma. Otolaryngol Head Neck Surg 2017;156:863-9. DOI PubMed
19. Kearney L, Hogan D, Conlon P, Roche M, O’Neill JP, O’Sullivan JB. High-risk cutaneous malignancies and immunosuppression:
Challenges for the reconstructive surgeon in the renal transplant population. J Plast Reconstr Aesthet Surg 2017;70:922-30. DOI
PubMed
20. Southwell KE, Chaplin JM, Eisenberg RL, McIvor NP, Morton RP. Effect of immunocompromise on metastatic cutaneous squamous
cell carcinoma in the parotid and neck. Head Neck 2006;28:244-8. DOI PubMed
21. Yilmaz M, Eskiizmir G, Friedman O. Cutaneous squamous cell carcinoma of the head and neck: management of the parotid and neck.
Facial Plast Surg Clin North Am 2012;20:473-81. DOI PubMed
22. Sahovaler A, Krishnan RJ, Yeh DH, et al. Outcomes of cutaneous squamous cell carcinoma in the head and neck region with regional
lymph node metastasis: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg 2019;145:352-60. DOI PubMed
PMC
23. Porceddu SV, Bressel M, Poulsen MG, et al. Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-
risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase iii trog 05.01 trial. J Clin Oncol 2018;36:1275-
83. DOI PubMed
24. Ch’ng S, Maitra A, Allison RS, et al. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic
cutaneous squamous cell carcinoma. J Surg Oncol 2008;98:101-5. DOI PubMed
25. Robsahm TE, Helsing P, Veierød MB. Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable
mortality. Cancer Med 2015;4:472-80. DOI PubMed PMC
26. Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel cell carcinoma, version 1.2018, NCCN clinical practice guidelines in oncology. J
Natl Compr Canc Netw 2018;16:742-74. DOI PubMed
27. Deneve JL, Messina JL, Marzban SS, et al. Merkel cell carcinoma of unknown primary origin. Ann Surg Oncol 2012;19:2360-6.
DOI PubMed PMC
28. Vandeven N, Lewis CW, Makarov V, et al. Merkel cell carcinoma patients presenting without a primary lesion have elevated markers
of immunity, higher tumor mutation burden, and improved survival. Clin Cancer Res 2018;24:963-71. DOI PubMed PMC
29. Rizzo JM, Harms PW, Harms KL, Plaska A, Brenner C, Durham AB. Unknown primary Merkel cell carcinoma in the
immunosuppressed patient: Case series. JAAD Case Rep 2021;8:19-22. DOI PubMed PMC
30. Pan Z, Chen YY, Wu X, et al. Merkel cell carcinoma of lymph node with unknown primary has a significantly lower association with
Merkel cell polyomavirus than its cutaneous counterpart. Mod Pathol 2014;27:1182-92. DOI PubMed
31. Bajetta E, Celio L, Platania M, et al. Single-institution series of early-stage Merkel cell carcinoma: long-term outcomes in 95 patients